These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 32700469)

  • 1. Risk Governance of Emerging Technologies Demonstrated in Terms of its Applicability to Nanomaterials.
    Isigonis P; Afantitis A; Antunes D; Bartonova A; Beitollahi A; Bohmer N; Bouman E; Chaudhry Q; Cimpan MR; Cimpan E; Doak S; Dupin D; Fedrigo D; Fessard V; Gromelski M; Gutleb AC; Halappanavar S; Hoet P; Jeliazkova N; Jomini S; Lindner S; Linkov I; Longhin EM; Lynch I; Malsch I; Marcomini A; Mariussen E; de la Fuente JM; Melagraki G; Murphy F; Neaves M; Packroff R; Pfuhler S; Puzyn T; Rahman Q; Pran ER; Semenzin E; Serchi T; Steinbach C; Trump B; Vrček IV; Warheit D; Wiesner MR; Willighagen E; Dusinska M
    Small; 2020 Sep; 16(36):e2003303. PubMed ID: 32700469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blueprint for a self-sustained European Centre for service provision in safe and sustainable innovation for nanotechnology.
    Marcoulaki E; López de Ipiña JM; Vercauteren S; Bouillard J; Himly M; Lynch I; Witters H; Shandilya N; van Duuren-Stuurman B; Kunz V; Unger WES; Hodoroaba VD; Bard D; Evans G; Jensen KA; Pilou M; Viitanen AK; Bochon A; Duschl A; Geppert M; Persson K; Cotgreave I; Niga P; Gini M; Eleftheriadis K; Scalbi S; Caillard B; Arevalillo A; Frejafon E; Aguerre-Chariol O; Dulio V
    NanoImpact; 2021 Jul; 23():100337. PubMed ID: 35559838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Embedding Ethical Impact Assessment in Nanosafety Decision Support.
    Malsch I; Isigonis P; Dusinska M; Bouman EA
    Small; 2020 Sep; 16(36):e2002901. PubMed ID: 32700443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Essential Elements of a Risk Governance Framework for Current and Future Nanotechnologies.
    Stone V; Führ M; Feindt PH; Bouwmeester H; Linkov I; Sabella S; Murphy F; Bizer K; Tran L; Ågerstrand M; Fito C; Andersen T; Anderson D; Bergamaschi E; Cherrie JW; Cowan S; Dalemcourt JF; Faure M; Gabbert S; Gajewicz A; Fernandes TF; Hristozov D; Johnston HJ; Lansdown TC; Linder S; Marvin HJP; Mullins M; Purnhagen K; Puzyn T; Sanchez Jimenez A; Scott-Fordsmand JJ; Streftaris G; van Tongeren M; Voelcker NH; Voyiatzis G; Yannopoulos SN; Poortvliet PM
    Risk Anal; 2018 Jul; 38(7):1321-1331. PubMed ID: 29240986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Necessity and approach to integrated nanomaterial legislation and governance.
    Wang J; Gerlach JD; Savage N; Cobb GP
    Sci Total Environ; 2013 Jan; 442():56-62. PubMed ID: 23178764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ITS-NANO--prioritising nanosafety research to develop a stakeholder driven intelligent testing strategy.
    Stone V; Pozzi-Mucelli S; Tran L; Aschberger K; Sabella S; Vogel U; Poland C; Balharry D; Fernandes T; Gottardo S; Hankin S; Hartl MG; Hartmann N; Hristozov D; Hund-Rinke K; Johnston H; Marcomini A; Panzer O; Roncato D; Saber AT; Wallin H; Scott-Fordsmand JJ
    Part Fibre Toxicol; 2014 Feb; 11():9. PubMed ID: 24521051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (Re)Conceptualizing decision-making tools in a risk governance framework for emerging technologies-the case of nanomaterials.
    Mullins M; Himly M; Llopis IR; Furxhi I; Hofer S; Hofstätter N; Wick P; Romeo D; Küehnel D; Siivola K; Catalán J; Hund-Rinke K; Xiarchos I; Linehan S; Schuurbiers D; Bilbao AG; Barruetabeña L; Drobne D
    Environ Syst Decis; 2023; 43(1):3-15. PubMed ID: 35912374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What can nanosafety learn from drug development? The feasibility of "safety by design".
    Hjorth R; van Hove L; Wickson F
    Nanotoxicology; 2017 Apr; 11(3):305-312. PubMed ID: 28303735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into possibilities for grouping and read-across for nanomaterials in EU chemicals legislation.
    Mech A; Rasmussen K; Jantunen P; Aicher L; Alessandrelli M; Bernauer U; Bleeker EAJ; Bouillard J; Di Prospero Fanghella P; Draisci R; Dusinska M; Encheva G; Flament G; Haase A; Handzhiyski Y; Herzberg F; Huwyler J; Jacobsen NR; Jeliazkov V; Jeliazkova N; Nymark P; Grafström R; Oomen AG; Polci ML; Riebeling C; Sandström J; Shivachev B; Stateva S; Tanasescu S; Tsekovska R; Wallin H; Wilks MF; Zellmer S; Apostolova MD
    Nanotoxicology; 2019 Feb; 13(1):119-141. PubMed ID: 30182766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Grouping of nanomaterials to read-across hazard endpoints: from data collection to assessment of the grouping hypothesis by application of chemoinformatic techniques.
    Lamon L; Asturiol D; Richarz A; Joossens E; Graepel R; Aschberger K; Worth A
    Part Fibre Toxicol; 2018 Sep; 15(1):37. PubMed ID: 30249272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Governance of nanotechnology and nanomaterials: principles, regulation, and renegotiating the social contract.
    Kimbrell GA
    J Law Med Ethics; 2009; 37(4):706-23. PubMed ID: 20122111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guidance for safe handling of nanomaterials.
    Dhawan A; Shanker R; Das M; Gupta KC
    J Biomed Nanotechnol; 2011 Feb; 7(1):218-24. PubMed ID: 21485878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards harmonisation of testing of nanomaterials for EU regulatory requirements on chemical safety - A proposal for further actions.
    Bleeker EAJ; Swart E; Braakhuis H; Fernández Cruz ML; Friedrichs S; Gosens I; Herzberg F; Jensen KA; von der Kammer F; Kettelarij JAB; Navas JM; Rasmussen K; Schwirn K; Visser M
    Regul Toxicol Pharmacol; 2023 Mar; 139():105360. PubMed ID: 36804527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A global view of regulations affecting nanomaterials.
    Hansen SF
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(5):441-9. PubMed ID: 20533518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards a more effective and efficient governance and regulation of nanomaterials.
    Teunenbroek TV; Baker J; Dijkzeul A
    Part Fibre Toxicol; 2017 Dec; 14(1):54. PubMed ID: 29258600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The UCD nanosafety workshop (03 December 2018): towards developing a consensus on safe handling of nanomaterials within the Irish university labs and beyond - a report.
    Stuttgen V; Giffney HE; Anandan A; Alabdali A; Twarog C; Belhout SA; O Loughlin M; Podhorska L; Delaney C; Geoghegan N; Mc-Fadden J; Alhadhrami NA; Fleming A; Phadke S; Yadav R; Fattah S; McCartney F; Alsharif SA; McCaul J; Singh K; Erikandath S; O Meara F; Wychowaniec JK; Cutrona MB; MacMaster G; Reynolds AL; Gaines S; Hogg B; Farrelly M; D Alton M; Coulahan P; Bhattacharjee S
    Nanotoxicology; 2019 Aug; 13(6):717-732. PubMed ID: 31111769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A roadmap to strengthen standardisation efforts in risk governance of nanotechnology.
    Rasmussen K; Bleeker EAJ; Baker J; Bouillard J; Fransman W; Kuhlbusch TAJ; Resch S; Sergent JA; Soeteman-Hernandez LG; Suarez-Merino B; Porcari A
    NanoImpact; 2023 Oct; 32():100483. PubMed ID: 37734653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Governance of Nanomaterials: Review of Criteria and Tools for Risk Communication, Evaluation, and Mitigation.
    Isigonis P; Hristozov D; Benighaus C; Giubilato E; Grieger K; Pizzol L; Semenzin E; Linkov I; Zabeo A; Marcomini A
    Nanomaterials (Basel); 2019 May; 9(5):. PubMed ID: 31060250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. State strategies of governance in biomedical innovation: aligning conceptual approaches for understanding 'Rising Powers' in the global context.
    Salter B; Faulkner A
    Global Health; 2011 Feb; 7():3. PubMed ID: 21349182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanomaterials in the Environment Acquire an "Eco-Corona" Impacting their Toxicity to Daphnia Magna-a Call for Updating Toxicity Testing Policies.
    Nasser F; Constantinou J; Lynch I
    Proteomics; 2020 May; 20(9):e1800412. PubMed ID: 31750982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.